Vaccines and SARS-CoV-2 variants: the urgent need for a correlate of protection
Lancet
.
2021 Apr 3;397(10281):1263-1264.
doi: 10.1016/S0140-6736(21)00468-2.
Epub 2021 Mar 23.
Author
Salim S Abdool Karim
1
Affiliation
1
Centre for the AIDS Programme of Research in South Africa, Durban 4013, South Africa; Department of Epidemiology, Columbia University, New York, USA. Electronic address: salim.abdoolkarim@caprisa.org.
PMID:
33765410
PMCID:
PMC7984864
DOI:
10.1016/S0140-6736(21)00468-2
No abstract available
Publication types
Letter
Comment
MeSH terms
Brazil
COVID-19 Vaccines
COVID-19*
ChAdOx1 nCoV-19
Humans
SARS-CoV-2
South Africa
United Kingdom
Viral Vaccines*
Substances
COVID-19 Vaccines
Viral Vaccines
ChAdOx1 nCoV-19